Join TelegramInstagram
Tradnexa

Indian stocks › AUROPHARMA

Aurobindo Pharma (AUROPHARMA) share price chart

Price data as of the close on 16 Nov 2026. Open the live chart for real-time prices, 50+ indicators and drawing tools.

Last close

1,794.00

Day change

-1.60%

52-week high

1,859.90

-3.54% from it

52-week low

1,106.00

+62.21% above it

1-month change

+7.62%

1-year change

+46.75%

Open AUROPHARMA live chart freePosition size calculator

About Aurobindo Pharma

Aurobindo Pharma is listed on the National Stock Exchange of India (NSE) under the symbol AUROPHARMA in the Pharma sector.

AUROPHARMA is part of NSE's futures and options (F&O) segment, so besides the shares, traders can trade AUROPHARMA futures and options contracts. F&O stocks are among the most liquid shares in India.

What you can see on Tradnexa

AUROPHARMA share: FAQ

What is the 52-week high and low of AUROPHARMA?

Over the last 52 weeks AUROPHARMA traded between a low of ₹1,106.00 and a high of ₹1,859.90. Its last close was ₹1,794.00, -3.54% from the high.

How much has AUROPHARMA moved in the last year?

AUROPHARMA is +46.75% over the last year and +7.62% over the last month, based on daily closing prices. Past moves don't tell you what happens next.

Is AUROPHARMA in the F&O segment?

Yes. Aurobindo Pharma is one of the stocks in NSE's futures and options segment, so AUROPHARMA futures and options are available. Lot sizes change from time to time; check your broker for the current one.

Where can I see a live AUROPHARMA chart for free?

Open the AUROPHARMA chart on Tradnexa and connect your own Upstox or Angel One account: the chart, indicators and drawing tools are free.

Does Tradnexa give buy or sell calls on AUROPHARMA?

No. Tradnexa is charting and analysis software, not a SEBI-registered research analyst, so it does not recommend buying or selling any Indian stock.

Market data for information only, not a recommendation to buy or sell. Prices are end-of-day; check your broker for live prices. Tradnexa is not a SEBI-registered investment adviser or research analyst.